Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1120-

  Jensen, P ^a   Hansen, S ^a   Moller B ^a   Leivestad, T ^a   Pfeffer, P ^a   Fauchald, P ^a  

^a CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE;

AGE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHRONOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AZATHIOPRINE; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; KIDNEY TRANSPLANTATION; MIDDLE AGED; NORWAY; PREDNISOLONE; RISK FACTORS; SKIN NEOPLASMS;

EID: 0344699469     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01928-9     Document Type: Conference Paper

References (6)

1. Blohmé I., Larkö O. Transplant Proc. 24:1992;313.
2. Roeger L.S., Sheil A.G.R., Disney A.P.S., et al. Clin Transpl. 6:1992;202.
3. Gruber S.A., Gillingham K., Sothern R.B., et al. Clin Transpl. 8:1994;388.
4. Bavinck J.N.B., Hardie D.R., Green A., et al. Transplantation. 61:1996;715.
5. Glover M.T., Deeks J.J., Raftery M.J., et al. Lancet. 349:1997;398.
6. Hiesse C., Rieu P., Kriaa F., et al. Transplant Proc. 29:1997;831.